prospec
Encephalitis Japanese 12kda

Encephalitis Japanese 12kda

  • Name
  • Description
  • Cat#
  • Pricings
  • Quantity
  • Encephalitis Japanese 12kda

  • Japanese Encephalitis Virus 12kda Recombinant
  • TBE-288
  • Shipped with Ice Packs

Catalogue number

TBE-288

Description

Recombinant Japanese Encephalitis Virus produced in E. coli contains 110 amino acids and having a Mw of 12kDa. Encephalitis Japanese is fused to a His tag at its N-terminus and purified by proprietary chromatographic technique.

Source

Escherichia Coli.

Physical Appearance

Sterile Filtered clear solution.

Formulation

Encephalitis Japanese solution contains PBS & 25mM K2CO3.

Stability

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).

Avoid multiple freeze-thaw cycles.

Purity

Protein is >95% pure as determined by 10% PAGE (coomassie staining).      

 

Applications

ELISA.

Safety Data Sheet

Usage

ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Background

Recombinant JEV is designed to elicit a strong immune response, making it a valuable tool for vaccine development. Studies have shown that rJEV can induce robust neutralizing antibodies and cellular immune responses in animal models, providing protection against wild-type JEV infection. Pathogenicity and Virulence Factors: rJEV is used to dissect the roles of various viral proteins in disease pathogenesis. By mutating specific genes, researchers can identify virulence factors and understand how the virus interacts with host cells and evades the immune system.

Back to Top